WO2008034202A3 - Traitement de la sclérose latérale amyotrophique - Google Patents
Traitement de la sclérose latérale amyotrophique Download PDFInfo
- Publication number
- WO2008034202A3 WO2008034202A3 PCT/BE2007/000107 BE2007000107W WO2008034202A3 WO 2008034202 A3 WO2008034202 A3 WO 2008034202A3 BE 2007000107 W BE2007000107 W BE 2007000107W WO 2008034202 A3 WO2008034202 A3 WO 2008034202A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lateral sclerosis
- amyotrophic lateral
- ivermectin
- derivates
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne un nouveau médicament pour le traitement médical d'une maladie du neurone moteur (MND) telle que la sclérose latérale amyotrophique. Plus particulièrement, la présente invention concerne l'utilisation de l'ivermectine et d'analogues, pour prévenir, retarder et améliorer une maladie du neurone moteur (MND) telle que la sclérose latérale amyotrophique (ALS) et la dégénérescence associée des neurones moteurs.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0618403.0 | 2006-09-19 | ||
GBGB0618403.0A GB0618403D0 (en) | 2006-09-19 | 2006-09-19 | Treatment of amyotrophic lateral sclerosis |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008034202A2 WO2008034202A2 (fr) | 2008-03-27 |
WO2008034202A3 true WO2008034202A3 (fr) | 2008-06-19 |
Family
ID=37421218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BE2007/000107 WO2008034202A2 (fr) | 2006-09-19 | 2007-09-19 | Traitement de la sclérose latérale amyotrophique |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0618403D0 (fr) |
WO (1) | WO2008034202A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9351988B2 (en) | 2011-05-02 | 2016-05-31 | Universite De Geneve | Macrocyclic lactones and use thereof |
CN103356687B (zh) * | 2012-10-19 | 2016-06-01 | 厦门大学 | 一种伊维菌素及其衍生物的用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992022302A1 (fr) * | 1991-06-07 | 1992-12-23 | Fractal Laboratories, Incorporated | Traitement d'affections humaines entrainant un dereglement ou un dysfonctionnement du systeme nerveux |
FR2790670A1 (fr) * | 1999-03-12 | 2000-09-15 | Aventis Pharma Sa | Association riluzole et antagoniste des recepteurs ampa |
JP2002047206A (ja) * | 2000-07-28 | 2002-02-12 | Taisho Pharmaceut Co Ltd | Gdnf産生促進剤、パーキンソン病治療剤およびals治療剤 |
US20060205757A1 (en) * | 2005-03-11 | 2006-09-14 | Mingqiang Zhang | 39-desmethoxyrapamycin, compositions and methods of use thereof |
-
2006
- 2006-09-19 GB GBGB0618403.0A patent/GB0618403D0/en not_active Ceased
-
2007
- 2007-09-19 WO PCT/BE2007/000107 patent/WO2008034202A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992022302A1 (fr) * | 1991-06-07 | 1992-12-23 | Fractal Laboratories, Incorporated | Traitement d'affections humaines entrainant un dereglement ou un dysfonctionnement du systeme nerveux |
FR2790670A1 (fr) * | 1999-03-12 | 2000-09-15 | Aventis Pharma Sa | Association riluzole et antagoniste des recepteurs ampa |
JP2002047206A (ja) * | 2000-07-28 | 2002-02-12 | Taisho Pharmaceut Co Ltd | Gdnf産生促進剤、パーキンソン病治療剤およびals治療剤 |
US20060205757A1 (en) * | 2005-03-11 | 2006-09-14 | Mingqiang Zhang | 39-desmethoxyrapamycin, compositions and methods of use thereof |
Non-Patent Citations (2)
Title |
---|
ANDRIES ET AL: "Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis", NEUROBIOLOGY OF DISEASE, BLACKWELL SCIENCE, OXFORD, GB, vol. 25, no. 1, 21 November 2006 (2006-11-21), pages 8 - 16, XP005727015, ISSN: 0969-9961 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; TAKI, SHIGEYUKI ET AL: "V-type ATPase inhibitors as GDNF formation promoters for treatment of Parkinson disease and ALS (amyotrophic lateral sclerosis )", XP002474492, retrieved from STN Database accession no. 2002:113136 * |
Also Published As
Publication number | Publication date |
---|---|
GB0618403D0 (en) | 2006-11-01 |
WO2008034202A2 (fr) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007104789A3 (fr) | Dérivés d'amyline | |
WO2009033821A3 (fr) | Utilisation d'un peptide en tant qu'agent thérapeutique | |
WO2007109024A3 (fr) | Analogues de la thiazolidinedione | |
WO2007128802A3 (fr) | Utilisation de flibansérine pour le traitement des troubles de la libido post-ménopausiques | |
HK1215960A1 (zh) | 用於治療視網膜變性疾病的改良方式 | |
WO2009043522A3 (fr) | Utilisation d'un peptide en tant qu'agent thérapeutique | |
WO2007048801A3 (fr) | Medicaments augmentant le desir sexuel comprenant des derives de benzimidazolone | |
UA94580C2 (ru) | Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием | |
WO2007127263A3 (fr) | Utilisations thérapeutiques d'urolithines | |
WO2008043544A8 (fr) | Composés de pyrazoline substitués par un groupe sulfonamide, préparation de ceux-ci et utilisation de ceux-ci en tant qu'inhibiteurs des cbl | |
WO2009002159A3 (fr) | Vaccin intradermique contenant un peptide de pvh | |
EP2139460A4 (fr) | Compositions et procédés permettant le diagnostic, le traitement et la prévention de la sclérose latérale amyotrophique et des maladies neurologiques apparentées | |
WO2009074247A8 (fr) | Nouveaux dérivés d'amide d'acide 2-arylthiazole-4-carboxylique, leur préparation et leur utilisation en tant que médicament | |
WO2007135426A3 (fr) | Traitement de maladies neurodégénératives | |
CA2646419C (fr) | Utilisation de la pentraxine longue ptx3 pour la prevention ou le traitement de maladies virales | |
WO2008043788A3 (fr) | Nouveaux composés | |
WO2005023833A3 (fr) | Traitement de maladies neurodegeneratives | |
WO2008152068A3 (fr) | Dérivés de [1,10]-phénanthroline pour le traitement de maladies neurodégénératives ou hématologiques | |
WO2006002846A3 (fr) | Nouveaux analogues de nitrobenzylthioinosine | |
WO2008034202A3 (fr) | Traitement de la sclérose latérale amyotrophique | |
WO2007115287A3 (fr) | Combinaison de composés organiques | |
WO2008094054A3 (fr) | Composés | |
WO2009074498A8 (fr) | Nouvelle utilisation médicale de l'orotate de propionate de 3-(2,2,2-triméthylhydrazine) | |
WO2009043525A3 (fr) | Utilisation d'un peptide en tant qu'agent thérapeutique | |
WO2006125818A3 (fr) | Formulation pharmaceutique destinee a la prevention et/ou au traitement de maladies cardiovasculaires et inflammatoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07815686 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07815686 Country of ref document: EP Kind code of ref document: A2 |